Marc Ullman spoke to Nutraingredients-USA about a new bill that would include CBD in the definition of dietary supplements in the federal Food, Drug and Cosmetic Act. The legislation is an attempt to cope with the raft of products now on the market that are technically illegal.

Marc said he thinks the bill will only

Marc Ullman was quoted in a Nutraingredients-USA story entitled “Warning letter analysis shows FDA has target on CBD, not hemp.”

To read the article, click here.

Marc Ullman was quoted in a Natural Products Insider article, “CBD industry hit with nearly half a dozen class action lawsuits.” The FDA’s batch of warning letters last month to CBD marketers spawned a growing number of proposed class action lawsuits.

Click here to read the article.

Marc Ullman was quoted in a Nutraingredients-USA article, “Appeals court decision, recent warning letters open door for more CBD suits.”

Click here to read article.

Marc Ullman is quoted in a Nutraingredients-USA article, “FDA revises consumer info on CBD, says ingredient is not GRAS, sends 15 CBD warning letters.”

Click here to read the article.

On December 4-5, Marc Ullman will be speaking at the 4th Annual Dietary Supplement Regulatory Strategy Conference at the Key Bridge Marriott in Arlington, VA.

Topics to be addressed include:

• Ongoing Impact of CBD Use in the Dietary Supplement Industry
• Regulatory Oversight of Social Media Influencers & Supplement Claims
• Interpretation of USDA National Bioengineered

Marc Ullman was quoted in a Nutra ingredients-usa.com article, “Mississippi adds to regulatory tangle with warning on CBD products.”

Click here to read article.

Marc Ullman will be a speaker at SupplySide West summit, “CBD from Seed to Shelf: The Supply Side Story.” Ullman’s session will be “Legal Eagles: Risk Update, Plus Your Questions Answered.” The Session will take place on Oct. 16 at Mandalay Bay, Las Vegas, NV.

Program Description:

Cannabinoids are on everyone’s mind—consumers, industry, regulators and

Marc Ullman was quoted in a NutraIngredients-usa.com article, “Patchwork quilt of regulations could further complicate CBD picture if FDA doesn’t act quickly.”

Click here to read the article.

Marc Ullman was quoted in the Long Island Business News’ article, “Confusing Web of Laws Muddles CBD Industry.” The article discusses the confusing web of contradictory laws and inconsistent enforcement in products containing CBD.

The sudden swell in CBD products stems in large part from the passage of the 2018 Farm Bill. CBD is derived